Aarti Drugs: The financial results for the period ended September 30, 2026
Aarti Drugs (AARTIDRUGS) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹4,256 crore.
What happened
Aarti Drugs (AARTIDRUGS) filed a disclosure with the exchanges on 3 November 2026 at 07:03 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
Aarti Drugs is a small-cap company in the Healthcare sector, with a market value of about ₹4,256 crore.
The stock last traded at ₹466.3, against a 52-week range of ₹319–₹534 (12.7% below the high).
Before this filing the shares had moved +7.8% over the month and +9.6% over three months. Average daily turnover over the last 20 sessions was about ₹34.59 crore.
Promoters held 54.43% at the end of Q1 FY27, down 0.60% points from the previous quarter; 2.50% of promoter shares were pledged. Foreign institutions owned 1.52% and domestic institutions 10.29%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 591 | 53.9 | 5.91 |
| Q2 FY26 | 653 | 45.3 | 4.95 |
| Q3 FY26 | 602 | 40.5 | 4.44 |
| Q4 FY26 | 720 | 55.2 | 6.05 |
| Q1 FY27 | 703 | 50.2 | 5.49 |
What history shows
This is not the company's first results disclosure: BCEIE has 2 earlier filings of this kind on record since May 2026.
Across 300 similar disclosures by other Healthcare companies, shares moved +1.3% on average the next day and +1.9% over five days; 57% of them rose the next day.
Market-wide, 10,321 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 3 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Ramky Infrastructure, Aarti Drugs and Syngene Lead Volume Gainers
- Aarti Drugs (AARTIDRUGS) Share Price Rises 12.25% Today: Price Action and Fundamental Analysis
- Volume Gainers Today, 28 October 2026 at 12:00 PM IST: Aarti Drugs Leads Volume Surge
- Pharma sector stocks today, October 22: Aarti Drugs falls 3.54%, Lupin down 2.39%, Strides Pharma drops 2.27%
- Aarti Drugs reports 38% net profit rise in Q2 FY27
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.